Heidelberg Pharma Partner Telix Pharmaceuticals Provides Regulatory Update on Imaging Agent TLX250-CDx Read more
Zemcelpro Wins EC Approval as First Cell Therapy for Blood Cancer Patients Without Suitable Donors Read more
Pfizer and BioNTech’s COMIRNATY Gets FDA Approval for Seniors and High-Risk Individuals Ages 5-64 Read more